Kidney transplantation is a pivotal treatment option for individuals with end-stage kidney disease (ESKD), offering improved quality of life and survival rates compared to long-term dialysis. This procedure involves replacing a diseased kidney with a healthy one from a living or deceased donor.
Prior to transplantation, a thorough evaluation is essential:
Blood Group Compatibility: Ensuring ABO compatibility between donor and recipient.
Human Leukocyte Antigen (HLA) Matching: Tissue typing to assess genetic compatibility, reducing the risk of rejection .
Panel Reactive Antibody (PRA) Testing: Identifying any pre-existing antibodies that may react against the donor's tissue.
Kidney Paired Donation (KPD): Facilitating transplants through paired exchanges when direct compatibility is not possible .
The transplantation involves two main surgeries:
Donor Nephrectomy: Removal of the kidney from the donor, often performed laparoscopically for minimal invasiveness.
Recipient Transplantation: Implantation of the donor kidney into the recipient's lower abdomen, connecting the renal artery, vein, and ureter to the recipient's vessels and bladder .
Post-operative management includes:
Immunosuppressive Therapy: To prevent organ rejection, tailored to the individual's needs.
Monitoring for Complications: Regular assessments for signs of infection, rejection, and graft function.
Lifestyle Modifications: Emphasis on a balanced diet, regular exercise, and avoiding nephrotoxic substances.
While kidney transplantation offers significant benefits, challenges remain:
Rejection Episodes: Acute or chronic rejection can occur, necessitating prompt intervention.
Infection Risks: Due to immunosuppressive therapy, increased susceptibility to infections.
Graft Survival: Long-term success depends on adherence to medication regimens and regular monitoring.
Recent studies have expanded the horizons of kidney transplantation:
HIV-Positive Donors and Recipients: Research indicates that kidney transplants between HIV-positive individuals are safe, with similar success rates to those without HIV .
Desensitization Protocols: Techniques like intravenous immunoglobulin (IVIG) therapy have enabled transplants between ABO-incompatible donors and recipients .
For more detailed information or to schedule a consultation, please contact:
Phone: +91 81081 67176
Website: https://drkeyurdave.com/